These findings demonstrate that CCL2 may play a particularly key role in PCa bone metastases, where it can contribute to tumor growth, invasion, angiogenesis, bone remodeling, and recruitment of pro-tumoral immune cells. The gene discussed is CCL2; the disease is neoplasm.